Streetwise Reports' Article Archives — July 2019 back to current month (135)
The designation, opinion and asset are discussed in a ROTH Capital Partners report.
The purpose is to empower a broad network of recruiters with the product.
The current headwinds facing the company and their expected impact are described in a BMO Capital Markets report.
The rationale and an explanation of the downgrade are discussed in a CIBC report.
Enphase Energy's shares are surging by more than 30% today after releasing strong growth and earnings for Q2/19.
The pipeline should drive revenue growth in that market into 2020.
South American Explorer's Stock Doubles on News Flow (07/30/2019)
In this interview, CEO Philip Thomas of A.I.S. Resources discusses his company's prospects in the lithium and manganese sectors with Peter Epstein of Epstein Research.
Zebra Technologies' shares are up 15% today after announcing Q2/19 earnings and plans for a $1 billion share repurchase.
Firm's Cannabis Flower Yield Surpasses Expectations (07/29/2019)
Also, the company begins growing a second strain.
As a result, the firm adds a fourth sensory component to its scanning platform.
Two individuals join the Canadian firm ahead of its expected growth spurt.
Technical Analyst: The Outlook for Oil Is Bleak (07/29/2019)
Technical analyst Clive Maund explains why he is bearish on oil and what could alter that outlook.
Mylan Gets a Shot in the Arm with Pfizer Merger Deal (07/29/2019)
EpiPen manufacturer Mylan N.V. announced that the company will merge with Pfizer Inc.'s Upjohn Division, which holds Pfizer's off-patent branded and generic drugs, forming a new company.
The Critical Investor looks beyond the headlines to analyze the factors behind the company's sale of its JV share to its partner.
A description of this minerals firm's findings and their implication are provided in a Haywood report.
A Raymond James report indicates how it expects market conditions to affect margins of this Texas-based company in H2/19.
Catasys: This Is Bigger Than You Think (07/26/2019)
Daniel Carlson of Tailwinds Research examines the "blockbuster" implications of a recent announcement about this company's OnTrak program.
The prognosis for online exchange operator eHealth Inc. looks positive as the company reported a 101% increase in Q2/19 revenues over the prior year period and raised full year 2019 revenue estimates by $50 million to $365–385 million, compared with previous guidance of $315–335 million for 2019.
HYRE Pads Balance Sheet (07/25/2019)
Financing allows the company to better woo partners, Daniel Carlson of Tailwinds Research explains.
Brian Ostroff, a partner at Windermere Capital, in this interview with Streetwise Reports, discusses three companies in his portfolio that he believes are poised to benefit from the rise in commodity prices.
Gold ETF That Makes a Difference (07/25/2019)
Bob Moriarty of 321Gold profiles a precious metals ETF that has "absolutely obliterated its main competition."
Central Bank Folly: Blame the Boomers (07/25/2019)
Sector expert Michael Ballanger muses on how the baby boom generation has impacted markets through time, and discusses how he will play the current precious metals bull.
Orthodontic and GP Dental medical device maker Align Technology announced a 24.6% increase in sales volume of its Invisalign products in its Q2/19 earnings report, but investors are not smiling much over China growth concerns as the shares of the company have fallen more than 25%.
The company is busy with projects in all phases, in four countries.
The aim and developments of the program are recapped in a CIBC report.
Royalty Company Focuses on Project Generation (07/24/2019)
In this interview with Maurice Jackson of Proven and Probable, the president and CEO of this royalty generator describes the business model and outlook for his firm.
Anixa Licenses Another Potential Blockbuster (07/24/2019)
Daniel Carlson of Tailwinds Research discusses a major collaboration with the Cleveland Clinic for his top pick stock of the year.
Viva Gold Ready to Expand Resource (07/24/2019)
Bob Moriarty of 321gold makes the case for investment in a gold stock that he believes is about to emerge from hibernation.
Edwards Lifesciences is trading higher after reporting higher than expected adjusted earnings for Q2/19. The company estimates that the FDA will approve its SAPIEN 3 valve and SAPIEN 3 Ultra system in Q3/19.
The Canadian company will keep drilling to elicit further information.
Also, the company closed two deals with Eric Sprott, a royalty sale and a private placement.
Four Junior Miners on Brien Lundin's Radar (07/23/2019)
Gold prices have been rising rapidly over the last few weeks and silver has begun to follow. Brien Lundin, editor of Gold Newsletter, in this interview with Streetwise Reports, profiles four junior miners that either have leverage to the metals prices or are sitting on large discoveries.
A Raymond James report looks at 2019, 2020 spending and production expectations for and by this company.
Silver Producer Achieves Strong Q2/19 Numbers (07/23/2019)
The company's recent production, costs and guidance are reviewed and discussed in this CIBC report.
The Critical Investor takes a look at recent news from this Nevada explorer, including the success of its recent oversubscribed CA$1.1M financing.
The company's most advanced assets are discussed in a Dawson James Securities report.
Miner to Sell 25% JV Interest to Partner (07/23/2019)
Divesting of its ownership, the company deems, is a momentous achievement.
The immuno-oncology company's findings are reviewed in a ROTH Capital Partners report.
The specifics and benefits of the deal are discussed in an H.C. Wainwright & Co. report.
In this interview with Maurice Jackson of Proven and Probable, Jayant Bhandari presents his world view and discusses how it meshes with investment in the precious metals markets.
The company discussed both its Alzheimer's disease and ALS programs.
The company has completed 6,500 meters of its current phase 1 program.
These assets complement the company's primary care clinics and telemedicine and electronic medical record functionality.
This satisfies all of the company's obligations under the purchase agreement.
Gold Update: Consolidation in Gold in the Forecast (07/22/2019)
Technical analyst Clive Maund charts the latest moves in the gold and precious metals markets.
Liberty Gold Hits Financing Jackpot (07/22/2019)
Bob Moriarty of 321 Gold explains how this explorer is cashed up and advancing two U.S. projects.
Silver Update: The Outlook Is 'Excellent' (07/22/2019)
The silver market is on the upswing but consolidation could be in the offing, according technical analyst Clive Maund.
The two California-based companies will collaborate on specific related development activities.
Peter Epstein of Epstein Research checks into the most recent developments announced by this company, which include planting 130,000 hemp plantlets on 40 acres.
RPM International reported increased quarterly and yearly sales results for FYE May 31, 2019. The firm predicts 2.5% to 4% sales growth in fiscal year 2020 noting that raw material cost inflation is moderating.
Threat Detection Platform Goes Global (07/20/2019)
The company continues to expand its sales network throughout the Americas, Europe, Africa, Asia and the Middle East.
One-Hour Delivery Firm to Launch Services in Toronto (07/20/2019)
This development is part of the Canadian company's strategy to expand nationally.
For this Nevada miner, 2019 should be a busy and interesting year of exploration, says Thibaut Lepouttre of the Caesars Report.
Skechers USA reported record global sales for the second quarter. International sales led the way in the quarter with an increase of 19.8% over the same period last year.
The FDA deemed the firm's submission for analgesic approval complete.
This development moves the Canadian company closer to profitability.
The force will integrate use of the product into its existing security procedures.
Peter Epstein of Epstein Research delves into the reasons why he believes this development—and other developments in the lithium market—strengthen the investment thesis.
Online and internet banking firm Ally Financial set a 52-week high intraday share price after announcing positive Q2/19 earnings. The company reported strong year-over-year percentage gains in revenues, earnings and deposits.
The study results and their meaning are reviewed in an H.C. Wainwright & Co. report.
The primary reason for the rating—upcoming trial results—is discussed in an Echelon Wealth Partners report.
The company with a Nevada lithium mine eyes commercial production, never done before with this geology.
This comes on the heels of another discovery by the company, nearby in the same fault zone.
This step moves the product further down the development track.
The product will be launched under its brand for the recreational market.
In this interview with Maurice Jackson of Proven and Probable, the president and CEO of a project generator working in the Goodpaster District of Alaska explains the rationale behind putting the company's stock on sale.
The Battle for Investment Relevancy (07/17/2019)
Sector expert Michael Ballanger is watching the gold market and banking on opportunities in silver.
Seattle Genetics announced a 28.3% increase in net sales for its second quarter 2019 powered by ADCETRIS sales along with a promising pipeline.
Irving Is About to Become a Gold Producer (07/17/2019)
Bob Moriarty of 321 Gold describes the latest developments for this miner.
A description of the asset and its potential are provided in a Dawson James report.
The company will keep taking its continually updated, model-driven approach to planning every drill hole.
These areas resulted from the Canadian company's recent historical data compilation and fieldwork related to the property.
Its newly entered agreement offers potential for future growth in Canada.
Ron Struthers of Struthers' Resource Stock Report discusses the gold bull market and one company that he believes investors should take a look at.
J.B. Hunt shares opened nearly 8% higher today after reporting Q2/19 earnings and a 6% increase in revenue over the same period in Q2/18.
Company Decides to Advance Peru Mine to Production (07/15/2019)
The rationale for the decision and the potential to further improve project economics are explored in a ROTH Capital Partners report.
Updated Resource Lifts Total Gold Ounces by 11% (07/15/2019)
The new numbers and their impact on the existing project are presented in a Haywood report.
The company's sports betting platform is enabling the rapid growth there.
Galapagos announced that Gilead Sciences has agreed to pay $3.95 billion for a 10-year partnership and licensing deal and will invest an additional $1.1 billion in newly issued shares of the company.
Recent drill results from the asset and its current resource are discussed in a Haywood report.
The asset's recent output and the company's exploration plans are provided in an Echelon Wealth Partners report.
Feasibility Study Reveals 'Attractive' Gold Project (07/13/2019)
The study's highlights are presented and discussed in a Canaccord Genuity report.
Drill results suggest the zone has ample depth potential and gold mineralization continuity.
With this agreement, the company will introduce its technology to the food preparation and cooking industry.
Technical analyst Clive Maund charts the stock of this company that has developed a device that uses a special light that visualizes cancer during minimally invasive surgery.
Illumina Inc. shares traded down more than 15% as the company reported lower preliminary Q2/19 revenues and updated its annual revenue guidance.
Uranium Explorer Set to Profit in Market Upswing (07/12/2019)
In this interview with Maurice Jackson of Proven and Probable, the head of this junior miner in the Athabasca Basin discusses recent developments in the uranium market and the projects his company is focused on the region.
This profitable small-cap company, which saw Q1 adjusted EBITDA increase 288% over the prior year, just announced landing a major client.
The combined company will provide exposure to both near- and longer-term projects.
The Canadian company remains well funded for this next program.
By divesting this asset, the company creates value for its shareholders.
CVS Healthcare announced a $0.50/share quarterly dividend yesterday and got an added boost today as news spreads regarding easing of federal restrictions on pharmacy rebate plans.
The reasons for the upgrade are provided in a BMO Capital Markets report.
A study description and expected data readouts this year are provided in a ROTH Capital Partners report.
The investment thesis on this immunotherapies developer is made in an H.C. Wainwright & Co. report.
Solar Solutions Firm Awarded New York City Contract (07/10/2019)
This work is being done to enhance the resiliency of small businesses in that locale against major weather events.
Intercepts are released for two more holes from this current exploration phase.
The two firms involved plan to have the offering fully rolled out by Q3/19.
Ramp-up at Valley of the Kings Mine On Schedule (07/10/2019)
Meanwhile, elsewhere on the property, the Canadian company continues exploration.
The company also is on the cusp of spudding an exploration well in Indonesia.
Palladium/Platinum Opportunity in Group Ten (07/10/2019)
Bob Moriarty of 321 Gold explains why he is a fan of this PGE explorer with a project in Montana.
McDermott International has been awarded a US$3 billion contract for Saudi Aramco. The company will partner with China Offshore Oil Engineering Company to increase production by 300,000 barrels per day.
Miner Advances Exploration at Flagship PGE Project (07/09/2019)
In this interview with Maurice Jackson of Proven and Probable, the president and CEO of this company describes the most recent developments at its Montana prospect.
The Charm of Fishing (07/09/2019)
Sector expert Michael Ballanger explores the analogies between fishing and investing.
Acacia Communications announced today that it will be acquired by Cisco Systems in an all cash deal.
Peter Epstein of Epstein Research explains why he believes this company stands out from many of the lithium explorers in Argentina.
Brian Leni, founder of Junior Stock Review, profiles a gold explorer with a project in Quebec in the prolific Abitibi Greenstone Belt.
Brixton Metals Focuses on the Atlin Gold Camp (07/08/2019)
This company working in British Columbia is awaiting assay results of a 1,000-meter hole at Thorn, kicking off its exploration season, explains Thibaut Lepouttre of the Caesars Report.
Sangamo Therapeutics and partner Pfizer reported positive results for phase 1/2 Alta study for hemophilia A at the International Society on Thrombosis and Hemostasis Congress in Melbourne, Australia.
The Phony Wealth Effect and Gold (07/08/2019)
Rudi Fronk and Jim Anthony, cofounders of Seabridge Gold, discuss what real wealth is and if financial assets should be considered real wealth.
The goal of the till geochemical survey is to identify high-grade drill targets in new areas, as well as increasing grade and tonnage at existing deposits, Resources Opportunities editor James Kwantes writes.
The entities are rolling out the integration to mutual clients.
The effort is being undertaken to further delineate discovery potential there.
Company Named 'Top Small-Cap Growth Story' (07/06/2019)
The reasons for the positive outlook are given in a Raymond James report.
A description of the current situation and near-term outlook were provided in a CIBC report.
In this exclusive interview, CEO Paul Cowley of First Vanadium discusses the vanadium market and his company's prospects with Peter Epstein of Epstein Research.
Gold Producer to Divest Nicaraguan Mines (07/05/2019)
The terms and benefits of the deal are discussed in a BMO Capital Markets report.
The reasons for the positive outlook are presented in a Pareto Securities report.
A description of the properties and how this precious metals company will benefit from their addition are provided in a CIBC report.
Recent drill results and their implications are presented in a ROTH Capital Partners report.
The case is made in a ROTH Capital Partners report for investing in this U.S.-based pharma having multiple shots on goal.
Health Technology Company Recuperating Well (07/03/2019)
Technical analyst Clive Maund charts a medical technology firm and explains why he believes it is an interesting speculative play.
The Canadian company will retain exposure to the asset, though, through a royalty.
The company temporarily stopped drilling to do the engineering work needed for submission.
Precious 'Mettle' (07/03/2019)
Precious metals expert Michael Ballanger discusses the mettle necessary to trade precious metals at this time.
Internet security leader Symantec's shares are soaring today on reports of advanced merger discussions with chip maker Broadcom.
The company remains in the first of a planned two-phase capital improvement project.
This arrangement will allow customers to purchase the security company's product without upfront costs.
Amarin shares are spiking up today by more than 12% on greater than five times 50-day average volume after the company updated its annual revenue forecast and plans for Vascepa.
Bioasis Engages With the FDA: Here's What It Means (07/02/2019)
Daniel Carlson of Tailwinds Research examines the implications of correspondence with the regulatory agency as the company advances its lead candidate addressing brain cancer.
An H.C. Wainwright & Co. report presented the investment bank's reasons for its bullish view on this California-based biotech.
The terms of the financial transaction and the potential reasons for it are discussed in a BTIG report.
Technical analyst Clive Maund charts the reasons why the recent gold breakout is genuine.
Silver Poised for a Breakout (07/01/2019)
Technical analyst Clive Maund discusses why he believes silver is amazingly cheap and a sure sign that a major precious metals sector bull market is starting.
Energy Company to Sell Gas Assets in Alberta (07/01/2019)
The acquiring midstream firm will take on completing the facility expansion.
|"We highlight the considerable exploration upside at MAG's Juanicipio."|
|"Sprott's investment gives MMG the funds to continue exploring Keno."|
|"GBR is one of the most active, well-financed junior explorers."|
|"NTAR is ready to take off strongly higher very soon."|
|"DRRX's psoriasis trial is on target for topline data by year-end 2019."|